IP Library Granted Patent US 8,706,223
Granted Patent B2
US 8,706,223 · App. 13/353,891 · Granted Apr 22, 2014

Preventative vagal stimulation

Inventors: Xiaohong Zhou (Woodbury, MN); Lilian Kornet (Maastricht, NL); Richard N. M. Cornelussen (Maastricht, NL); Paul D. Ziegler (Minneapolis, MN); Robert Stadler (Shoreview, MN); Eduardo Warman (Maple Grove, MN); Karen J. Kleckner (New Brighton, MN); Lucy Nichols (Maple Grove, MN); Alberto Della Scala (Rome, IT)
Assignee: Medtronic, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,706,223
App. No.
13/353,891
Granted
Apr 22, 2014
Kind
B2
Abstract

The disclosure herein relates generally to methods for treating heart conditions using vagal stimulation, and further to systems and devices for performing such treatment. Such methods may include monitoring physiological parameters of a patient, detecting cardiac conditions, and delivering vagal stimulation (e.g., electrical stimulation to the vagus nerve or neurons having parasympathetic function) to the patient to treat the detected cardiac conditions.

Claims (21)

1. A device for use in treating a patient using vagal stimulation comprising:

monitoring apparatus configured to monitor physiological parameters of a patient, wherein the monitoring apparatus comprises at least one electrode to monitor the electrical activity of the patient's heart;

a sensing module coupled to the monitoring apparatus and configured to receive the monitored physiological parameters;

a therapy delivery module configured to deliver electrical stimulation to the patient's vagus nerve; and

a control module coupled to the sensing module and to the therapy delivery module and configured to:

determine an increased risk of myocardial infarction or myocardial ischemia using the monitored physiological parameters,

determine an increase in sympathetic activity using the monitored physiological parameters, and

initiate delivery of preventative electrical stimulation to the patient's vagus nerve upon at least one indication of an increase in sympathetic activity and if an increased risk of myocardial infarction or myocardial ischemia is determined to decrease at least one of workload and inflammation of the patient's heart.

2. The device of claim 1 , wherein the control module is further configured to determine an increased risk of myocardial infarction or myocardial ischemia using the monitored physiological parameters by determining whether the electrical activity of the patient's heart comprises a ST-deviation.

3. The device of claim 1 , wherein the preventative electrical stimulation is controlled by a schedule programmed in memory to be delivered to the patient's vagus nerve more than once a day.

4. The device of claim 1 , wherein determining an increase in sympathetic activity comprises determining that the patient has awaken from sleep using the monitored physiological parameters.

5. The device of claim 1 , wherein the control module is further configured to adjust the preventative electrical stimulation delivered to the patient's vagus nerve based on an analysis of the monitored physiological parameters until the P-R intervals within the electrical activity of the patient's heart have increased to a level that reduces the workload of the patient's heart.

6. A method for use in treating a patient using vagal stimulation comprising:

monitoring physiological parameters of a patient, wherein the physiological parameters comprise the electrical activity of the patient's heart;

determining an increased risk of myocardial infarction or myocardial ischemia using the monitored physiological parameters;

determining an increase in sympathetic activity using the monitored physiological parameters; and

delivering preventative electrical stimulation to the patient's vagus nerve upon at least one indication of an increase in sympathetic activity and if an increased risk of myocardial infarction or myocardial ischemia is determined to decrease at least one of workload and inflammation of the patient's heart.

7. The method of claim 6 , wherein determining an increased risk of myocardial infarction or myocardial ischemia using the monitored physiological parameters comprises determining whether the electrical activity of the patient's heart comprises a ST-deviation.

8. The method of claim 6 , wherein the method further comprises delivering the preventative electrical stimulation one or more selected times per day set per a schedule.

9. The method of claim 6 , wherein determining an increase in sympathetic activity comprises determining that the patient has awaken from sleep.

10. The method of claim 6 , wherein the method further comprises adjusting the preventative electrical stimulation delivered to the patient's vagus nerve based on an analysis of the monitored physiological parameters until the P-R intervals within the electrical activity of the patient's heart have increased to a level that reduces the workload of the patient's heart.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 2, 2012
From: ZHOU, XIAOHONG; KORNET, LILIAN; CORNELUSSEN, RICHARD N.M.; ZIEGLER, PAUL D; STADLER, ROBERT; WARMAN, EDUARDO; KLECKNER, KAREN J; NICHOLS, LUCY; DELLA SCALA, ALBERTO
To: MEDTRONIC, INC.
Reel/Frame 027974/0532 →
Continuity (2)
Provisional Application 61434265 · Jan 19, 2011
Related Publication 20120185010A1 · Jul 19, 2012